An early-stage clinical trial assessing an investigational vaccine to stave off Nipah virus infection has been started by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health. Produced by Moderna, Inc. in Cambridge, Massachusetts, the experimental vaccine was developed in collaboration with the NIAID’s Vaccine Research Center. […]
The post NIH Conducts Clinical Trial of The mRNA Nipah Virus Jab first appeared on World Pharma Today.This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here